Entrada Therapeutics
TRDA
TRDA
105 hedge funds and large institutions have $210M invested in Entrada Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 23 reducing their positions, and 25 closing their positions.
Holders
105
Holders Change
-6
Holders Change %
-5.41%
% of All Funds
1.41%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
44
Reduced
23
Closed
25
Calls
$38K
Puts
–
Net Calls
+$38K
Net Calls Change
-$65K
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FFO
126
Fortitude Family Office
Scottsdale,
Arizona
| – | – | -37 | Closed |
|
|
CCM
127
Coldstream Capital Management
Bellevue,
Washington
| – | – | -33 | Closed |
|
|
RIL
128
Rothschild Investment LLC
Chicago,
Illinois
| – | – | -20 | Closed |
|
129
Amundi
Paris,
France
| – | – | -12 | Closed |
|
|
SS
130
SBI Securities
Tokyo,
Japan
| – | – | -1 | Closed |
|
131
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|